Completed PHASE4 INTERVENTIONAL 2-arm NCT00716573

Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure (COREV)

COREV : A Multi-center, Randomized, Open-label Study Evaluating the Efficacy on Renal Function of Everolimus in Heart Transplant Recipients With Established Chronic Renal Failure

Sponsor: Hospices Civils de Lyon

Conditions Cardiac Transplantation Chronic Renal Insufficiency

Interventions everolimus

Updated 6 times since 2017 Last updated: Jun 19, 2017 Started: Sep 16, 2008 Primary completion: Apr 17, 2014 Completion: Apr 17, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00716573, this PHASE4 trial focuses on Cardiac Transplantation and Chronic Renal Insufficiency and remains completed. Sponsored by Hospices Civils de Lyon, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jul 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Jul 2017 [monthly]

Unknown Status PHASE4

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyon, France